China Still Phasing Out D4T AIDS Drug Three Years After WHO Urged End
This article was originally published in PharmAsia News
China, three years after the World Health Organization recommended it, has decided to phase out use of the D4T AIDS drug, identified in 2009 as having long-term, irreversible side effects.
You may also be interested in...
The company said its own calculations suggest a mid-November readout could yield a positive result, keeping it on track for an EUA before the end of 2020.
Dr Reddy’s management clears air on ransomware attack and says all critical operations are being enabled in a 'controlled and cautious' manner. The Indian firm also shared a timeline for its partnered Russian COVID-19 vaccine amid a free supply chorus in India.
Regardless of who wins, China seems to be looking beyond the 3 November US General Election, instead pouring in large resources to elevate its domestic health sector on a par with international standards, creating opportunities and profoundly impacting many areas from novel therapy development to investment decisions.